Results 91 to 100 of about 2,139 (156)

Chemiluminescence Immunoassay and Enzyme-Linked Immunosorbent Assay in the Diagnosis of Pemphigoid and Pemphigus: A Comparative Study. [PDF]

Int J Mol Sci
Wang Y, Fan Z, Zhang J, Bai M, Qin JL, Hu CJ, Zuo YG.   +6 more
europepmc   +1 more source

Recurrent bullous eruptions predominantly involving previously treated breast cancer sites. [PDF]

JAAD Case Rep
Namba M, Kogawa K, Terada A, Matsuzaki Y, Rokunohe D, Murai T, Akasaka E.   +6 more
europepmc   +1 more source

Brunsting-Perry Pemphigoid of the Scalp with Antibodies against Laminin 332 [PDF]

, 2011
S. Zgažarová, Zgazarova, S., A. Niedermeier, M. Hertl, Hertl, M., H. Jedlickova, Jedlickova, H., Niedermeier, A.   +7 more
core   +1 more source

Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients. [PDF]

Acta Derm Venereol
Pira A, Merli M, Mariotti F, Andreani M, Marzano AV, De Simone C, Falcone R, Testa G, Battarra M, Romagnuolo M, Sollena P, De Galitiis F, Antiga E, Maglie R, Didona D, Sinagra JLM, Caproni M, Hertl M, Cozzani E, Vezzoli P, Calabrese L, Paolino G, Verkhovskaia S, Fania L, Gasparini G, Giampetruzzi AR, Didona B, Quaglino P, Di Zenzo G.   +28 more
europepmc   +1 more source

Personalized Biologic Therapy for Refractory Bullous Pemphigoid: Sequential Omalizumab, Dupilumab, and Rituximab. [PDF]

Clin Cosmet Investig Dermatol
Yu L, Hu G, Zhang Q, Zhu Y, Chen L, Chen J.   +5 more
europepmc   +1 more source

Immune-checkpoint inhibitor-induced bullous pemphigoid in patients with metastatic renal cell carcinoma: two case reports and systematic review of the literature. [PDF]

Acta Oncol
Filis P, Lindskog M, Curman P, Kuzmina N, Krantz Å, Chatzidionysiou K, Costa Svedman F, Zerdes I.   +7 more
europepmc   +1 more source

Dupilumab enables glucocorticoid withdrawal in refractory multisite mucous membrane pemphigoid: a case report. [PDF]

Front Med (Lausanne)
Hu Y, Xu LL, Li KH, Yu CS, Wang SB.
europepmc   +1 more source

Peristomal bullous pemphigoid: expanding the spectrum of localized presentations. [PDF]

An Bras Dermatol
Ramírez-Bravo F, Contreras CA, Marcet GH, Martínez IW, Urrutia MJ, Castro A.   +5 more
europepmc   +1 more source

Anti‐BP230 antibody–positive bullous pemphigoid complicated by ulcerative colitis

Journal of Cutaneous Immunology and Allergy, 2019
Mayu Fujimoto, Yasutomo Imai, Chiharu Tateishi, Daisuke Tsuruta, Kiyofumi Yamanishi   +4 more
doaj   +1 more source

A Multicenter Analysis of Patients with Bullous Pemphigoid: Clinical Characteristics and Insights into Drug-Associated Disease. [PDF]

Int J Mol Sci
Małolepsza A, Kośny A, Juczyńska K, Czerwińska J, Jałowska M, Dmochowski M, Dańczak-Pazdrowska A, Owczarczyk-Saczonek A, Walecka I, Kowalewski C, Woźniak K, Zajdel R, Żebrowska A.   +12 more
europepmc   +1 more source